vs
Side-by-side financial comparison of GREENE COUNTY BANCORP INC (GCBC) and Spero Therapeutics, Inc. (SPRO). Click either name above to swap in a different company.
GREENE COUNTY BANCORP INC is the larger business by last-quarter revenue ($22.2M vs $12.6M, roughly 1.8× Spero Therapeutics, Inc.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs 46.3%, a 204.3% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs 23.8%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs 18.9%).
Bank of Greene County is an American federally-chartered savings bank headquartered in Catskill, NY. The bank's branches are located in the Upstate New York counties of Greene, Columbia, Albany, Ulster, and Rensselaer.
GCBC vs SPRO — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $22.2M | $12.6M |
| Net Profit | $10.3M | $31.5M |
| Gross Margin | — | — |
| Operating Margin | 52.0% | — |
| Net Margin | 46.3% | 250.7% |
| Revenue YoY | 23.8% | 24080.8% |
| Net Profit YoY | 37.4% | 250.9% |
| EPS (diluted) | $0.60 | $0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $22.2M | $12.6M | ||
| Q3 25 | $21.5M | $0 | ||
| Q2 25 | $20.5M | $0 | ||
| Q1 25 | $20.1M | $12.0K | ||
| Q4 24 | $17.9M | $52.0K | ||
| Q3 24 | $16.9M | $65.0K | ||
| Q2 24 | $16.6M | $114.0K | ||
| Q1 24 | $15.7M | $140.0K |
| Q4 25 | $10.3M | $31.5M | ||
| Q3 25 | $8.9M | $-7.4M | ||
| Q2 25 | $9.3M | $-1.7M | ||
| Q1 25 | $8.1M | $-13.9M | ||
| Q4 24 | $7.5M | — | ||
| Q3 24 | $6.3M | $-17.1M | ||
| Q2 24 | $6.7M | $-17.9M | ||
| Q1 24 | $5.9M | $-12.7M |
| Q4 25 | 52.0% | — | ||
| Q3 25 | 47.4% | — | ||
| Q2 25 | 53.5% | — | ||
| Q1 25 | 44.6% | -122758.3% | ||
| Q4 24 | 45.0% | — | ||
| Q3 24 | 39.6% | -28604.6% | ||
| Q2 24 | 41.2% | -16720.2% | ||
| Q1 24 | 39.4% | -9987.1% |
| Q4 25 | 46.3% | 250.7% | ||
| Q3 25 | 41.2% | — | ||
| Q2 25 | 45.6% | — | ||
| Q1 25 | 40.1% | -115550.0% | ||
| Q4 24 | 41.7% | — | ||
| Q3 24 | 37.1% | -26380.0% | ||
| Q2 24 | 40.6% | -15668.4% | ||
| Q1 24 | 37.3% | -9049.3% |
| Q4 25 | $0.60 | $0.56 | ||
| Q3 25 | $0.52 | $-0.13 | ||
| Q2 25 | $0.55 | $-0.03 | ||
| Q1 25 | $0.47 | $-0.25 | ||
| Q4 24 | $0.44 | — | ||
| Q3 24 | $0.37 | $-0.32 | ||
| Q2 24 | $0.39 | $-0.33 | ||
| Q1 24 | $0.34 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $40.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $258.3M | $59.0M |
| Total Assets | $3.1B | $68.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $40.3M | ||
| Q3 25 | — | $48.6M | ||
| Q2 25 | — | $31.2M | ||
| Q1 25 | $155.5M | $48.9M | ||
| Q4 24 | $166.4M | $52.9M | ||
| Q3 24 | — | $76.3M | ||
| Q2 24 | $190.4M | $63.5M | ||
| Q1 24 | — | $82.3M |
| Q4 25 | $258.3M | $59.0M | ||
| Q3 25 | $248.2M | $26.5M | ||
| Q2 25 | $238.8M | $32.8M | ||
| Q1 25 | $229.0M | $33.8M | ||
| Q4 24 | $218.4M | $46.1M | ||
| Q3 24 | $216.3M | $65.5M | ||
| Q2 24 | $206.0M | $80.5M | ||
| Q1 24 | $199.2M | $96.2M |
| Q4 25 | $3.1B | $68.9M | ||
| Q3 25 | $3.1B | $54.2M | ||
| Q2 25 | $3.0B | $62.1M | ||
| Q1 25 | $3.0B | $77.7M | ||
| Q4 24 | $3.0B | $110.5M | ||
| Q3 24 | $2.9B | $135.2M | ||
| Q2 24 | $2.8B | $149.9M | ||
| Q1 24 | $2.9B | $167.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $6.4M | $-8.4M |
| Free Cash FlowOCF − Capex | $6.2M | — |
| FCF MarginFCF / Revenue | 28.0% | — |
| Capex IntensityCapex / Revenue | 0.9% | — |
| Cash ConversionOCF / Net Profit | 0.62× | -0.26× |
| TTM Free Cash FlowTrailing 4 quarters | $47.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.4M | $-8.4M | ||
| Q3 25 | $7.0M | $17.4M | ||
| Q2 25 | $28.0M | $-17.7M | ||
| Q1 25 | $7.3M | $-4.0M | ||
| Q4 24 | $5.3M | $-23.4M | ||
| Q3 24 | $2.1M | $12.8M | ||
| Q2 24 | $24.9M | $-18.7M | ||
| Q1 24 | $5.6M | $5.9M |
| Q4 25 | $6.2M | — | ||
| Q3 25 | $6.5M | — | ||
| Q2 25 | $27.3M | — | ||
| Q1 25 | $7.3M | — | ||
| Q4 24 | $5.1M | — | ||
| Q3 24 | $2.0M | — | ||
| Q2 24 | $23.4M | — | ||
| Q1 24 | $4.9M | — |
| Q4 25 | 28.0% | — | ||
| Q3 25 | 30.4% | — | ||
| Q2 25 | 133.3% | — | ||
| Q1 25 | 36.1% | — | ||
| Q4 24 | 28.6% | — | ||
| Q3 24 | 11.8% | — | ||
| Q2 24 | 141.2% | — | ||
| Q1 24 | 31.3% | — |
| Q4 25 | 0.9% | — | ||
| Q3 25 | 1.9% | — | ||
| Q2 25 | 3.4% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 1.0% | — | ||
| Q3 24 | 0.9% | — | ||
| Q2 24 | 9.1% | — | ||
| Q1 24 | 4.2% | — |
| Q4 25 | 0.62× | -0.26× | ||
| Q3 25 | 0.78× | — | ||
| Q2 25 | 3.00× | — | ||
| Q1 25 | 0.91× | — | ||
| Q4 24 | 0.71× | — | ||
| Q3 24 | 0.34× | — | ||
| Q2 24 | 3.70× | — | ||
| Q1 24 | 0.95× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
